Dizhi Pharmaceuticals: 991,100 restricted shares from the 2020 stock option incentive plan will be listed for trading.

Dizhe Pharmaceuticals announced that the 991,073 shares to be listed for the first time are the second tranche of shares to be issued and exercised before the initial public offering, and the second tranche of shares to be sold in the second exercise period of the 2020 Employee Stock Option Plan. These shares account for 0.21% of the company's total share capital and are held by 105 shareholders. These shares were registered on February 16, 2023, with a lock-up period of 36 months, and will be eligible for trading starting from February 24, 2026. Due to share incentive plans and targeted issuances, the company's total share capital has changed. As of the announcement date, the company's total share capital is 464,633,342 shares.